Advanced search
Publication Cover
American Orthoptic Journal Volume 56, 2006 - Issue 1
Journal homepage
27
Views
3
CrossRef citations to date
0
Altmetric
The John Pratt-Johnson Annual Lecture

Neuro-Ophthalmology and Multiple Sclerosis

Charles E. MaxnerDepartments of Medicine and Ophthalmology, Dalhousie University, Halifax, Nova Scotia, Canada.
, M.D., F.R.C.P.C.
Pages 72-85 | Published online: 22 Dec 2017

References

  • Murray TJ. Multiple Sclerosis: The History of a Disease. New York: Demos Medical Publishing; 2005.
  • Noseworthy JH, Lucchinetti C, Rodriquez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000; 343: 938–952.
  • Bhan V, Brown MG, Fisk JD, et al: Prevalence estimates of multiple sclerosis in Nova Scotia. Multiple Sclerosis: Clinical and Laboratory Research 2005; 11 (Supp. 1): 105.
  • Sadovnik D: Genes and environment: A clinical update. Neurol Transmission 2004; 5: 4–6.
  • Peterson JW, Trapp BD: Neuropathobiology of multiple sclerosis. Neurol Clin 2005; 23: 107–129.
  • Frohman EM, Goodin DS, Calabresi PA, et al: The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003; 61: 602–611.
  • Traboulsee A, Zhao G, Li DKB: Neuroimaging in multiple sclerosis. Neurol Clin 2005; 23: 131–148.
  • McDonald WI, Compston A, Edan G, et al: Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121–127.
  • Goodin DS, Frohman EM, Germany GP, et al: Disease modifying therapies in multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 2002; 58: 169–178.
  • Lublin FD: Clinical features and diagnosis of multiple sclerosis. Neurol Clin 2005; 23: 1–15.
  • POptic Neuritis Study Group: The clinical profile of optic neuritis: Experience of the optic neuritis treatment trial. Arch Ophthalmol 1991; 109: 1673–1678.
  • Beck RW, Cleary PA, Anderson MM, et al, and the Optic Neuritis Study Group: A randomized controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992; 326: 581–588.
  • Miller DH, Newton MR, van der Poel JC, et al: Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology 1988; 38: 175–179.
  • Selhorst JB, Saul RF: Uhthoff and his symptom. J Neuroophthalmol 1995; 15: 63–69.
  • Scholl GB, Song HS, Wray SH: Uhthoff's symptom in optic neuritis: Relationship to magnetic resonance imaging and development of multiple sclerosis. Ann Neurol 1991; 30: 180–184.
  • Davis FA, Bergen D, Schauf C, et al: Movement phosphenes in optic neuritis: A new clinical sign. Neurology 1976; 26: 1100–1104.
  • Gregory RL. Eye and Brain: The Psychology of Seeing. 2nd ed. New York: McGraw-Hill Book Co.; 1973. p. 80.
  • POptic Neuritis Study Group: The 5-year risk of MS after optic neuritis: Experience of the optic neuritis treatment trial. Neurology 1997; 49: 1404–1413.
  • Jacobs LD, Beck RW, Simon JH, et al: Intramuscular interferon b-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000; 343: 898–904.
  • Comi G, Fillippi M, Barkhof F, et al: Effect of early treatment on conversion to definite multiple sclerosis: A randomized study. Lancet 2001; 357: 1576–1582.
  • Arnold AC: Evolving management of optic neuritis and multiple sclerosis. Am J Ophthalmol 2005; 139: 1101–1108.
  • Anderson D, Cox T: Visual symptoms and signs. In: Paty DW, Ebers GC, eds. Multiple Sclerosis. Philadelphia: F.A. Davis Company; 1998. pp. 229–256.
  • Bamford CR, Ganley JP, Sibley WA, Laguna JF: Uveitis, perivenous sheathing and multiple sclerosis. Neurology 1978; 28: 119–124.
  • Arnold AC, Pepose JS, Hepler RS, Foos RY: Retinal periphlebitis and retinitis in multiple sclerosis: I. Pathologic characteristics. Ophthalmology 1984; 91: 255–262.
  • Lightman S, McDonald WI, Bird AC, et al: Retinal venous sheathing in optic neuritis. Brain 1987; 110: 405–414.
  • Jacobs DA, Galetta SL: Multiple sclerosis and the visual system. Ophthalmol Clin North Am 2004; 17: 265–273.
  • Frohman TC, Frohman EM, O'Suilleabhain P, et al: Accuracy of clinical detection of INO in MS. Neurology 2003; 61: 848–850.
  • Frohman EM, Zhang H, Kramer PD, et al: MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis. Neurology 2001; 57: 762–768.
  • Frohman EM, Solomon D, Zee DS: Nuclear, supranuclear and internuclear eye movement abnormalities in multiple sclerosis. Int MS J 1995; 2: 79–89.
  • Lee AG: Multiple sclerosis and nystagmus. Am Orthopt J 2005; 55: 24–27.
  • Derwenskus JA, Serra A, Downey D, et al: Abnormal eye movements predict disability in multiple sclerosis (MS): Two-year follow-up. Neurology 2003; 5 (Supp. 1): P01.024.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.